Viewing nowGlimawin Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Cosmax Pharma Co., Ltd.

MFDS item code 201901300 · Approved 2019.03.01 · Insurance code 055100880
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps with blood sugar control in patients with type 2 diabetes by complementing dietary and exercise therapies. It can be used alone, and may also be administered in combination when sufficient blood sugar control is not achieved with oral hypoglycemic agents or insulin alone. Especially in cases where blood sugar control is difficult with sulfonylureas or metformin alone, this medication can be used alongside metformin to more effectively improve blood sugar control. Therefore, this medication plays an important role in improving blood sugar control in the management of type 2 diabetes.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medication is administered orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses exceeding 4 mg, although some patients have shown better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medication. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation of this medication may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medication There is no precise dose equivalence between this medication and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medication, it is advisable to follow the method described under Initial dose. That is, initiate treatment at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medication. 4) Dose adjustment during treatment While taking this medication, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. Generally, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical attention and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medication is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or diabetic coma. Additionally, it should not be administered to those who are allergic to this medication or sulfonylureas. Experience with this medication in patients with severely impaired liver or kidney function is lacking, and insulin therapy is recommended instead. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. In cases of severe infection, preoperative or postoperative conditions, or severe trauma, it is advisable to switch to insulin therapy. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious, as irregular absorption of the medication could increase the risk of hypoglycemia. This medication contains lactose, so it should not be taken by patients with lactose intolerance or galactose metabolism disorders. During the first week of taking this medication, there is an increased risk of hypoglycemia, so blood sugar levels should be meticulously monitored. Special attention should be paid to elderly patients, those with poor nutritional status or irregular meal patterns, cases where muscle exercise and carbohydrate intake do not match, and any changes in eating patterns. Patients who frequently consume alcohol or have impaired kidney or liver function, or those who have taken an overdose of this medication are at a greater risk of hypoglycemia and should be closely monitored. Patients with endocrine disorders such as thyroid or adrenal dysfunction may also be affected in their hypoglycemia control. If this medication is combined with other drugs, there may be interactions, so it is important to inform your doctor or pharmacist. This medication lowers blood sugar levels, so hypoglycemic symptoms may arise. Symptoms of hypoglycemia include headaches, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and decreased consciousness, potentially leading to coma in severe cases. If hypoglycemia occurs, immediate intake of sugar is necessary to relieve symptoms, and if symptoms are severe, treatment at a hospital is required. Additionally, while taking this medication, transient visual disturbances, gastrointestinal symptoms, liver dysfunction, blood abnormalities, and allergic reactions may occur, so any abnormal symptoms should be reported to a doctor immediately. This medication should be taken regularly in combination with dietary and exercise therapy, and it is crucial to continuously monitor blood sugar control. If hypoglycemia occurs, sugar should be ingested immediately, and it is advisable to always carry sugar. In stressful situations such as surgery, infection, or trauma, blood sugar control may become difficult, necessitating a switch to insulin therapy. If other diseases arise during treatment or if lifestyle habits change, dosages should be adjusted in consultation with a physician. This medication may interact with other drugs and can affect blood sugar control depending on the medications taken concurrently. Particular caution should be exercised when combined with specific antibiotics, antifungals, anticoagulants, beta-blockers, and steroids. Additionally, alcohol consumption may affect the efficacy of this medication, so caution is advised. Pregnant or breastfeeding women should not take this medication as it may be harmful to the fetus or newborn, and it is recommended to switch to insulin therapy or discontinue breastfeeding if necessary. This medication is not to be used in children under 18 years of age, as its safety and efficacy have not been established. In elderly patients, renal function may be decreased, so dosing should be carefully adjusted. In cases of overdose, severe hypoglycemia may occur, requiring immediate treatment at a hospital, and in emergency situations, administration of glucose should be performed to rapidly increase blood sugar levels. This medication should be kept out of reach of children and should be stored in its original container sealed safely.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain room temperature between 1 degree and 30 degrees when storing.
Green rectangular tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Cosmax Pharma Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.